Glenn Russell Dubin’s Highbridge Capital Management Llc Disclosed New Egalet Corp Position

July 17, 2017 - By Peter Erickson

 Glenn Russell Dubin's Highbridge Capital Management Llc Disclosed New Egalet Corp Position

Investors sentiment increased to 1.89 in 2016 Q4. Its up 0.68, from 1.21 in 2016Q3. It is positive, as 6 investors sold Egalet Corp shares while 13 reduced holdings. 17 funds opened positions while 19 raised stakes. 14.72 million shares or 1.09% less from 14.88 million shares in 2016Q3 were reported.

Glenmede Trust Na reported 150 shares stake. Quantbot Technology L P accumulated 4,200 shares or 0% of the stock. 148,590 were reported by Wall Street. Meeder Asset Management Incorporated owns 1,705 shares. 261,025 were reported by Hightower Advsrs Ltd. Goldman Sachs Group Inc has invested 0% of its portfolio in Egalet Corp (NASDAQ:EGLT). Deutsche Bank Ag holds 0% or 13,713 shares. Rhumbline Advisers holds 25,000 shares or 0% of its portfolio. Manufacturers Life Insur The accumulated 0% or 16,050 shares. Susquehanna Grp Inc Ltd Liability Partnership has invested 0% of its portfolio in Egalet Corp (NASDAQ:EGLT). 309,886 are held by Vanguard Group. Ny State Common Retirement Fund accumulated 22,800 shares or 0% of the stock. Credit Suisse Ag reported 0% of its portfolio in Egalet Corp (NASDAQ:EGLT). Marshall Wace Limited Liability Partnership holds 0% of its portfolio in Egalet Corp (NASDAQ:EGLT) for 45,172 shares. 13,273 are held by Nationwide Fund Advsrs.

The New Glenn Russell Dubin’s Highbridge Capital Management Llc Holding in Egalet Corp

Highbridge Capital Management Llc reported SC 13G form with the SEC for Egalet Corp. Access it here: 000090266417002950. As reported by Glenn Russell Dubin’s Highbridge Capital Management Llc, the filler owns 9.58% or 4,120,800 shares of the Health Care–company.

Egalet Corp stake is new for [reportingPerson]. Date of activity: July 6, 2017. This shows Glenn Russell Dubin’s Highbridge Capital Management Llc’s positive view for Egalet Corp. For a hedge fund managing $32.39 billion in assets and having 310+ experts this is interesting position.

The hedge fund is investor in the Health Care sector. In the manager’s last 13-F, we saw 12% of Glenn Russell Dubin’s Highbridge Capital Management Llc’s portfolio is in the sector.

Egalet Corp Institutional Sentiment

Filings show 39 investors own Egalet Corp. The ownership in Q3 2015 is low, at 65.29 % of the outstanding shares. This is increased by 12477645. 17196177 were owned by these investors. 15 funds opened new Egalet Corp stakes, 13 increased positions. There were 9 that closed positions and 6 reduced them.

Apis Capital Advisors Llc is an investor bullish on Egalet Corp, owning 16000 shares as of Q3 2015 for 0.29% of its portfolio. Sphera Funds Management Ltd owns 325000 shares or 0.55% of its portfolio. NY Broadfin Capital Llc have 0.83% of its portfolio for 1134750 shares. Further, Wall Street Associates reported stake worth 0.83% of its portfolio. The CA Venbio Select Advisor Llc owns 440606 shares. Egalet Corp is 1.51% of its portfolio.

Business Profile

Egalet Corporation is a specialty pharmaceutical company. The Company is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. The Company’s products include OXAYDO and SPRIX Nasal Spray. The Company is developing two late-stage product candidates, ARYMO ER and Egalet-002 using Guardian Technology. The Company’s product SPRIX Nasal Spray, which contains ketorolac tromethamine is a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level. The Company’s product OXAYDO is an approved immediate-release (IR) oxycodone product formulated to deter abuse through snorting. The Company’s product candidate, ARYMO ER is an abuse-deterrent (AD), extended-release (ER), oral morphine formulation. The Company’s product candidate, Egalet-002, is an abuse-deterrent, extended-release, oral oxycodone formulation.

SEC Form 13G.

Glenn Russell Dubin’s Highbridge Capital Management Llc website.

About 533,469 shares traded. Egalet Corp (NASDAQ:EGLT) has declined 46.67% since July 17, 2016 and is downtrending. It has underperformed by 63.37% the S&P500.

Egalet Corporation is a specialty pharmaceutical company. The company has market cap of $36.65 million. The Firm is engaged in developing, manufacturing and commercializing treatments for pain and other conditions. It currently has negative earnings. The Company’s products include OXAYDO and SPRIX Nasal Spray.

Egalet Corp (NASDAQ:EGLT) Ratings Coverage

Among 2 analysts covering Egalet Ltd (NASDAQ:EGLT), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Egalet Ltd has $1500 highest and $6 lowest target. $7’s average target is 363.58% above currents $1.51 stock price. Egalet Ltd had 6 analyst reports since November 4, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, November 4. The rating was maintained by Cantor Fitzgerald on Wednesday, June 7 with “Buy”. The stock of Egalet Corp (NASDAQ:EGLT) has “Buy” rating given on Thursday, June 1 by Cantor Fitzgerald. The firm has “Market Outperform” rating given on Friday, July 14 by JMP Securities. The firm earned “Buy” rating on Friday, June 9 by JMP Securities. Cantor Fitzgerald maintained the stock with “Buy” rating in Tuesday, June 13 report.

More notable recent Egalet Corp (NASDAQ:EGLT) news were published by: Investorplace.com which released: “3 Stocks to Watch on Thursday: Egalet Corp (EGLT), Herman Miller, Inc. (MLHR …” on July 06, 2017, also Prnewswire.com with their article: “Egalet Announces Proposed Public Offering of Common Stock and Warrants” published on July 05, 2017, Nasdaq.com published: “Mid-Day Market Update: Crude Oil Up Over 2%; Egalet Shares Plummet” on July 06, 2017. More interesting news about Egalet Corp (NASDAQ:EGLT) were released by: Prnewswire.com and their article: “Egalet Corporation Announces Changes to Board of Directors” published on April 10, 2017 as well as Streetinsider.com‘s news article titled: “Form 8-K Egalet Corp For: Jun 20” with publication date: June 20, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.